Karyopharm Therapeutics Inc. short interest in 2024
In 2024, Karyopharm Therapeutics Inc.'s disclosed short interest ran from 16.31% of shares outstanding on 12 Jan 2024 to 15.53% on 31 Dec 2024, a change of -0.78 percentage points. The year's high was 20.48% on 15 Apr 2024 and its low 14.12% on 31 Oct 2024, averaging 16.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 45.80 days on 29 Nov 2024. Full history: Karyopharm Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 16.31% (12 Jan 2024)
- End of year
- 15.53% (31 Dec 2024)
- Change
- -0.78 pp
- High
- 20.48% (15 Apr 2024)
- Low
- 14.12% (31 Oct 2024)
- Average
- 16.54%
- Highest days to cover
- 45.80 (29 Nov 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 16.31% | 15.95 | results (8-K) |
| 31 Jan 2024 | 16.50% | 19.84 | |
| 15 Feb 2024 | 20.46% | 5.67 | |
| 29 Feb 2024 | 20.37% | 13.75 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 20.10% | 15.82 | |
| 28 Mar 2024 | 19.94% | 25.30 | |
| 15 Apr 2024 | 20.48% | 23.33 | |
| 30 Apr 2024 | 14.92% | 13.54 | |
| 15 May 2024 | 14.92% | 13.06 | 10-Q filed, results (8-K) |
| 31 May 2024 | 17.12% | 15.49 | |
| 14 Jun 2024 | 18.17% | 17.49 | |
| 28 Jun 2024 | 18.39% | 8.55 | |
| 15 Jul 2024 | 16.05% | 16.11 | |
| 31 Jul 2024 | 14.74% | 19.32 | |
| 15 Aug 2024 | 14.64% | 28.28 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 14.85% | 43.47 | |
| 13 Sep 2024 | 14.38% | 34.45 | |
| 30 Sep 2024 | 14.92% | 24.44 | |
| 15 Oct 2024 | 14.13% | 20.09 | |
| 31 Oct 2024 | 14.12% | 18.59 | |
| 15 Nov 2024 | 15.11% | 22.30 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 15.10% | 45.80 | |
| 13 Dec 2024 | 15.79% | 16.48 | |
| 31 Dec 2024 | 15.53% | 14.77 |
See also: Karyopharm Therapeutics Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.